Benzinga
Filament Health Announces FDA Authorization Of Phase 2 Clinical Trial Studying Psilocybin For Alcohol Use Disorder And Post-Traumatic Stress Disorder In Veterans and First Responders
Just one single dose of ‘magic mushrooms’ could relieve depression for 5 years, researchers find
Filament Health Enters Into Exclusive License Agreement With University Of Alabama at Birmingham For Data From A Clinical Trial Of Psilocybin For The Treatment Of Cocaine Use Disorder
